SCHEMBL7467650

SCHEMBL7467650

CCOC(=O)c1ncn(C(c2ccccc2)(c2ccccc2)c2ccccc2)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.48
ALOX12 P18054 1/20 0.48
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
GABRG2 P18507 3/20 0.44
GABRB3 P28472 3/20 0.44
GABRA5 P31644 3/20 0.44
GABRA1 P14867 2/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
MAPT P10636 3/20 0.43
HSD17B10 Q99714 2/20 0.43
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HPGD P15428 2/20 0.42
ELANE P08246 1/20 0.42
PDE4D Q08499 1/20 0.42
NPSR1 Q6W5P4 2/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9571780 0.85 GABRG2 (0.42) TP53ALOX12NPC1RAB9AGABRG2
SCHEMBL923644 0.81 LMNA (0.37) NPC1RAB9AMAPTHSD17B10ALDH1A1
SCHEMBL4963197 0.76 TP53 (0.58) TP53ALOX12NPC1RAB9AGABRG2
SCHEMBL7082785 0.76 TP53 (0.42) TP53ALOX12NPC1RAB9AGABRG2
SCHEMBL1564315 0.76 TSHR (0.41) TP53ALOX12NPC1RAB9AGABRG2
SCHEMBL312703 0.75 TSHR (0.38) NPC1ALDH1A1LMNASMN1; SMN2
SCHEMBL7319418 0.75 LMNA (0.35) MAPTALDH1A1KDM4ELMNA
SCHEMBL23496544 0.74 NPC1 (0.48) TP53ALOX12NPC1RAB9AMAPT
SCHEMBL4958152 0.74 TSHR (0.54) TP53ALOX12NPC1RAB9AALDH1A1
SCHEMBL1562700 0.74 MAPT (0.45) TP53ALOX12NPC1RAB9AGABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed
US-5140034-A Hydroxytryptamine receptor antagonists; psychological and gastrointestinal disorders MERCK SHARP & DOHME LTD. (GB) 1992-08-18 US disclosed